Key Events This Week
8 Jun: New 52-week high at Rs.551.25
9 Jun: All-time high reached at Rs.578
10 Jun: Sustained 52-week high of Rs.578
12 Jun: Week closes at Rs.546.20 (+1.35% on day)
Jun 25, 03:30 PM
BSE+NSE Vol: 4.79 lacs

With a decisive surge to Rs 597.4 on 23 Jun 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, marking a 33.42% gain over the past year and significantly outperforming the Sensex, which declined 6.92% in the same period. This milestone comes amid a complex market backdrop where the broader indices have faltered, underscoring the stock’s strong price momentum and technical alignment.
Read full news article
The Sensex declined 0.74% on 23 Jun 2026 while Shilpa Medicare Ltd surged 7.03%, touching an intraday high of Rs 588.4. This 6.26-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the company’s current position as of 20 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
With a decisive break above Rs 588.65 on 18 Jun 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, extending its impressive 25.81% gain over the past year against the Sensex’s decline of 5.21%. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and steady price appreciation.
Read full news article
8 Jun: New 52-week high at Rs.551.25
9 Jun: All-time high reached at Rs.578
10 Jun: Sustained 52-week high of Rs.578
12 Jun: Week closes at Rs.546.20 (+1.35% on day)

With a decisive break above Rs 578 on 10 Jun 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, extending its impressive 21.62% gain over the past year against the Sensex’s decline of 9.63%. This milestone reflects a strong technical momentum that has been building steadily over recent sessions.
Read full news article
Surging past its previous peaks, Shilpa Medicare Ltd touched a fresh 52-week high of Rs 578 on 09 Jun 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market.
Read full news article
The Sensex edged up 0.55% on 09 Jun 2026, but Shilpa Medicare Ltd outpaced the broader market with a 7.23% gain, reaching an intraday high of Rs 557.2. This 3.76-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 May 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 09 June 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleShilpa Medicare Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Shilpa Medicare Limited has informed the Exchange regarding Board meeting held on November 09, 2019.
Shilpa Medicare Limited has informed the Exchange regarding ''.
No Upcoming Board Meetings
Shilpa Medicare Ltd has declared 100% dividend, ex-date: 17 Sep 25
Shilpa Medicare Ltd has announced 1:2 stock split, ex-date: 06 Nov 15
Shilpa Medicare Ltd has announced 1:1 bonus issue, ex-date: 03 Oct 25
No Rights history available